Diferencia entre revisiones de «Propylthiouracil»
(Created page with "==Administration== *Type: Antithyroid *Dosage Forms: *Routes of Administration: *Other common names: PTU ==Adult Dosing== *Thyroid storm: 500-1000mg PO loading dose, followed...") |
|||
| (No se muestran 3 ediciones intermedias de 3 usuarios) | |||
| Línea 13: | Línea 13: | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
* >6yo: 50 mg PO daily, carefully uptitrated | *>6yo: 50 mg PO daily, carefully uptitrated | ||
==Special Populations== | ==Special Populations== | ||
| Línea 26: | Línea 26: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
''Both PTU and methimazole can cause agranulocytosis and hepatotoxicity, but to a lesser extent with methimazole'' | |||
*Agranulocytosis, aplastic anemia | *Agranulocytosis, aplastic anemia | ||
*Hepatotoxicity, liver failure | *Hepatotoxicity, liver failure | ||
*Nephritis | *Nephritis | ||
*Vasculitis | *Vasculitis | ||
===Common=== | ===Common=== | ||
*Rash | *Rash | ||
| Línea 50: | Línea 52: | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Endocrinology]] | |||
Revisión actual - 06:03 10 dic 2019
Administration
- Type: Antithyroid
- Dosage Forms:
- Routes of Administration:
- Other common names: PTU
Adult Dosing
- Thyroid storm: 500-1000mg PO loading dose, followed by 250mg PO q4h
- Hyperthyroidism
- Initial: 50-300mg PO TID (based on severity)
- Maintenance: 50mg PO TID
- 1st trimester pregnancy: Use lowest dose needed to keep maternal total T3/T4 slightly above normal range for pregnancy, TSH suppressed, and free T4 at or slightly above upper limit of normal for nonpregnant women. Switch to methimazole for 2nd-3rd trimester
Pediatric Dosing
- >6yo: 50 mg PO daily, carefully uptitrated
Special Populations
- Pregnancy Rating: D - see dosing note above
- Lactation risk: Infant risk cannot be ruled out
- Renal dosing: No adjustment
- Hepatic dosing:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Both PTU and methimazole can cause agranulocytosis and hepatotoxicity, but to a lesser extent with methimazole
- Agranulocytosis, aplastic anemia
- Hepatotoxicity, liver failure
- Nephritis
- Vasculitis
Common
- Rash
Pharmacology
- Half-life: 0.9-4.3h
- Metabolism: Hepatic
- Excretion: Renal
Mechanism of Action
- Inhibits thyroperoxidase, blocking thyroid hormone synthesis in the thyroid. In target tissues, blocks 5'-deiodinase, thereby inhibiting conversion of T4 to active T3